Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Antisense Pharma
Woman and Man
Between 18 years and 70 years
Antisense Pharma
Update Il y a 4 ans
ANTISENSE SAPPHIRE : Essai de phase 3 randomisé comparant l’efficacité et la tolérance du trabedersen ou d’une chimiothérapie standard par témozolomide et BCNU, chez des patients ayant un astrocytome anaplasique. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
Efficacy and safety of AP 12009 in adult patients with recurrent or refractory anaplastic astrocytoma as compared to standard treatment with temozolomide or BCNU: a randomized, actively controlled, op...
Country
France
organs
Cerveau
Specialty
Thérapies Ciblées
,
Chimiothérapie
Essai clos aux inclusions
More information